4.6 Article

Tfeb-Mediated Transcriptional Regulation of Autophagy Induces Autosis during Ischemia/Reperfusion in the Heart

Journal

CELLS
Volume 11, Issue 2, Pages -

Publisher

MDPI
DOI: 10.3390/cells11020258

Keywords

autophagic cell death; autosis; Tfeb; ischemia; reperfusion

Categories

Funding

  1. U.S. Public Health Service [HL67724, HL91469, HL102738, HL112330, HL138720, HL144626, HL150881, AG23039]
  2. American Heart Association Merit Award 20 Merit [35,120,374]
  3. Fondation Leducq Transatlantic Network of Excellence [15CVD04]
  4. Ministry of Science and ICT through the National Research Foundation of Korea [2021H1D3A2A02039802]
  5. National Research Foundation of Korea [2021H1D3A2A02039802] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Autosis is a unique form of cell death caused by dysregulated autophagy. During the late phase of ischemia/reperfusion in the heart, Tfeb is activated and translocated into the nucleus, leading to the upregulation of genes related to autophagy and lysosomal function, which promotes autosis.
Autosis is a unique form of cell death with characteristic morphological and biochemical features caused by dysregulated autophagy. Autosis is observed in the heart during the late phase of ischemia/reperfusion (I/R), when marked accumulation of autophagosomes is induced. We previously showed that the excessive accumulation of autophagosomes promotes autosis in cardiomyocytes. Although the inhibition of autophagic flux via the upregulation of Rubicon induces the accumulation of autophagosomes during I/R, it appears that additional mechanisms exacerbating autophagosome accumulation are required for the induction of autosis. Here, we show that Tfeb contributes to the induction of autosis during the late phase of I/R in the heart. During myocardial reperfusion, Tfeb is activated and translocated into the nucleus, which in turn upregulates genes involved in autophagy and lysosomal function. The overexpression of Tfeb enhanced cardiomyocyte death induced by a high dose of TAT-Beclin 1, an effect that was inhibited by the downregulation of Atg7. Conversely, the knockdown of Tfeb attenuated high-dose TAT-Beclin1-induced death in cardiomyocytes. Although the downregulation of Tfeb in the heart significantly decreased the number of autophagic vacuoles and inhibited autosis during I/R, the activation of Tfeb activity via 3,4-dimethoxychalcone, an activator of Tfeb, aggravated myocardial injury during I/R. These findings suggest that Tfeb promotes cardiomyocyte autosis during the late phase of reperfusion in the heart.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available